FdaApplication
ANDA 211186
Identifiers
- fda_app_no: ANDA211186
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2023-08-03 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 400MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 200MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 800MG | TABLET;ORAL |
| ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE | 600MG | TABLET;ORAL |
4 products